Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardization of Artemisia, Platanus, and D. farinae Extracts
NCT02474836Phase 2Completed
- Sponsor
- ROXALL Medizin GmbH
- Start
- Nov 2012
- Primary completion
- Sep 2013
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of artemisia vulgaris pollen allergen extract, platanus acerifolia allergen extract, dermatophagoides farinae extract in Hypersensitivity, sponsored by ROXALL Medizin GmbH. Started Nov 2012; status: completed.
02
Drugs
artemisia vulgaris pollen allergen extractplatanus acerifolia allergen extractdermatophagoides farinae extract
03
Conditions
Hypersensitivity
Beyond the preview
Go deeper on NCT02474836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474836.